Risiko for smitte med donorblod i danmark ved årtusindskiftet

Ugeskrift for Laeger

Volumn 163, Issue 19, 2001, Pages 2628-2632

  Dickmeiss, Ebbe ^a   Christiansen, Annette Hartvig ^b   Smith, Else ^b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; DENMARK; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MASS SCREENING; RISK FACTOR;

BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DENMARK; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 0035821512     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dickmeiss E, Christiansen AH, Smith E. Screening af donorblod for virale markører. Ugeskr Læger 2001; 163: 2623-8.
2. Busch MP, Kleinman S. Nucleic acid amplification testing and disease transmission. Transfusion 2000; 40: 143-6.
3. Schriber JR, Busch MP, Kleinman S, Korelitz JJ. The risk of transfusion-transmitted diseases. N Engl J Med 1996; 334: 1685-90.
4. Murthy KK, Henrard DR, Eichberg JW, Cobb KE, Busch MP, Allain JP et al. Redefining the HIV-infectious window period in the Chimpanzee model: evidence suggest that viral nucleic acid testing can prevent blood-borne transmission. Transfusion 1999; 39: 688-93.
5. Peterson J, Green G, Lida K, Kerrison P, Bernich S, Caldwell B et al. Detection of Hepatitis C core antigen in the antibody negative "window" phase of hepatitis C infection. Vox Sang 2000; 78: 80-5.
6. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA [letter]. Lancet 2000; 355: 41-2.
7. Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993; 307: 1095-7.
8. Courouce AM, Pillonel J, Saura C. Screening of blood donations for HTLV I/II.Transf Med Rev 1999; 13: 267-74.
9. Tokudome S, Tokunaga O, Shimamoto Y, Miyamoto Y, Sumida I, Kikuchi M et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res 1989; 49: 226-8.
10. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3: 1096-101.
11. Fretz C, Fournel JJ, Gluckmann JC, De The G. HTLV-I transmission and myelopathy induced by blood transfusion. Transfusion 1991; 31: 379.
12. Donegan E, Lee H, Operskalski EA, Busch MP et al. Transfusion transmission of retroviruses: HTLV I and II compared with HIV-1. Transfusion 1994; 34: 478-83.
13. Christensen PB, Groenbaek K, Krarup HB. Transfusion acquired hepatitis C: the Danish lookback experience. Transfusion 1999; 39: 188-93. The Danish HCV Lookback Group.
14. Birkmeyer JD, Goodnough JP, AuBuchon JP, Noordsji PG, Littenberg G. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993; 33: 544-51.
15. Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, Tuman KJ, Ivankowich AD. Autologous blood donation: hermodynamics in a high risk patient population. Transfusion 1992; 32: 17-22.
16. Katzenstein T, Nielsen C, Gerstoft J. Nosokomiel hiv transmission på en dansk hospitalsafdeling. Ugeskr Læer 1999; 161: 6364-5.
17. Jørgensen J, Taaning E. Dansk registrering af Transfusionskomplikationer. Rapport til: Dansk Selskab for Winisk Immunologi. København, 2000: 1-12.